Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01034917
Recruitment Status : Completed
First Posted : December 18, 2009
Last Update Posted : October 25, 2012
Information provided by (Responsible Party):
Dra. EUGENIA NEGREDO PUIGMAL, Fundacio Lluita Contra la SIDA